# Industry and Biotech Helping biotech and industry make the connection RareKids-CAN partners with industry to strengthen and accelerate the pediatric rare disease clinical trials ecosystem across Canada. Through our coordinated national network of pediatric research sites, investigators, patient and family partners, and centralized operational supports, we help streamline study planning, feasibility assessments, harmonized ethics review, site start up and execution within Canada’s pediatric rare disease clinical trial landscape. We can help you connect with the expertise, infrastructure, sites and research teams needed to move research forward.  How we support industry Need to expand your pediatric rare disease clinical trial across Canada? Leverage RareKids-CAN's national network and established investigator relationships to identify potential sites and accelerate engagement. Our Clinical Trial Navigators, based at 16 pediatric institutions and affiliated hospitals across Canada, leverage established relationships to conduct targeted outreach on behalf of study teams. This personalized approach helps improve engagement, accelerate investigator responses, and streamline the site identification site identification for pediatric rare disease clinical trials. Our proven relationship driven approach enables rapid investigator engagement and response, helping industry identify and connect with potential sites more efficiently. Need to navigate Health Canada requirements? Get specialized regulatory support designed for the unique needs of pediatric rare disease clinical trials. Our regulatory team brings more than 20 years of experience working with Health Canada and provides specialized support for pediatric rare disease clinical trials involving drugs, devices, natural health products, gene and cell therapies, and antisense oligonucleotides. From early preclinical regulatory guidance and submission strategy to Quality/CMC content and Investigator Brochure development, RareKids-CAN can help sponsors navigate the regulatory pathway with greater clarity and confidence. Managing ethics approval across multiple sites in Canada? Access our centralized ethics support designed to reduce administrative complexities and help keep pediatric clinical trials moving. RareKids-CAN facilitates centralized ethics submissions across participating sites, helping coordinate the review process, minimize duplication, and support more efficient study start up. Our centralized approach helps sponsors move from ethics submission to site activation more efficiently, while simplifying coordination across multiple institutions and jurisdictions. Incorporate the perspectives of patients and families into your clinical trial planning. RareKids-CAN facilitates meaningful engagement with patient partners to help ensure studies reflect community priorities, address real world needs, and support the development of more patient-centered pediatric rare disease clinical trials. Request a consultation Have Questions? RareKids-CAN is here to help. If you can’t find answers to your questions in our FAQs, please don’t hesitate to contact us. View our FAQs Request a Consultation